| November 28, 2023

Spiderwort Executive Joins Canada’s Premier Biotech Leadership Development Program

Dr. Stephen Hanson, Spiderwort Business Development Director, Joins Elite Cohort

Ottawa, Canada — November,28, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce its Business Development Director, Dr. Stephen Hanson, has been selected to participate in the prestigious adMare Academy Executive Institute

The adMare Executive Institute stands at the forefront of leadership cultivation in Canada’s life sciences ecosystem. The mission of the Executive Institute is to “build Canadian life science industry leaders who drive the innovation economy.” Designed to foster growth and learning in the industry, the program is notably discerning — admitting only 20 participants annually

“I’m honoured to be selected in this year’s cohort. The program’s emphasis on leadership growth inclusive of executives from start-ups to large enterprises promises to be an enriching learning experience.” said, Dr. Hanson, “The prospect of collaborating with other prominent leaders in the field, learning from their experience and strategies, and then weaving those insights into Spiderwort’s commercial fabric is something I’m looking forward to.”

Bringing the unique perspective of a nimble start-up, Dr. Hanson is keen on leveraging the benefits of continuous development. “Life-long learning is a journey, not a destination. This program is a testament to that belief,” he remarked.

The significance of this selection is a testament to Dr. Hanson’s high potential in the industry, as illustrated by his commitment and dedication to championing Spiderwort’s innovation in both spinal cord injury treatments and medical aesthetics. 

About Spiderwort
Spiderwort is transforming biotechnology with a platform of cellulose-based biomaterials that serve as the scaffolds for the regenerative medicine of the future. Spiderwort’s biomaterials have shown promise in the treatment of spinal cord injuries and soft tissue regeneration. Spun out as a startup from the Pelling Lab, Spiderwort is led by CEO Charles M. Cuerrier and inspired by the work of CSO and TED Fellow Andrew E. Pelling. Learn more at spiderwortbio.com

Media Contact

Shannon Murphy

Hear More From Us